Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 54,794Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Syngene International Limited

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

ODEVIXIBAT SESQUIHYDRATE

NDC Package Code : 84101-002

Start Marketing Date : 2021-04-06

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

Looking for 501692-44-0 / Odevixibat API manufacturers, exporters & distributors?

Odevixibat manufacturers, exporters & distributors 1

88

PharmaCompass offers a list of Odevixibat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Odevixibat manufacturer or Odevixibat supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Odevixibat manufacturer or Odevixibat supplier.

PharmaCompass also assists you with knowing the Odevixibat API Price utilized in the formulation of products. Odevixibat API Price is not always fixed or binding as the Odevixibat Price is obtained through a variety of data sources. The Odevixibat Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Odevixibat

Synonyms

501692-44-0, Azd8294, A4250, Ar-h064974, Odevixibat [usan], A-4250

Cas Number

501692-44-0

Unique Ingredient Identifier (UNII)

2W150K0UUC

About Odevixibat

Odevixibat, or A4250, is an ileal sodium/bile acid cotransporter inhibitor indicated for the treatment of pruritus in patients older than 3 months, with progressive familiar intrahepatic cholestasis (PFIC). Odevixibat is the first approved non-surgical treatment option for PFIC. Previous therapies for PFIC included a bile acid sequestrant such as [ursodeoxycholic acid]. Odevixibat was granted FDA approval on 20 July 2021.

Odevixibat Manufacturers

A Odevixibat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Odevixibat, including repackagers and relabelers. The FDA regulates Odevixibat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Odevixibat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Odevixibat manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Odevixibat Suppliers

A Odevixibat supplier is an individual or a company that provides Odevixibat active pharmaceutical ingredient (API) or Odevixibat finished formulations upon request. The Odevixibat suppliers may include Odevixibat API manufacturers, exporters, distributors and traders.

click here to find a list of Odevixibat suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Odevixibat NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Odevixibat as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Odevixibat API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Odevixibat as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Odevixibat and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Odevixibat NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Odevixibat suppliers with NDC on PharmaCompass.

Odevixibat Manufacturers | Traders | Suppliers

Odevixibat Manufacturers, Traders, Suppliers 1
24

We have 1 companies offering Odevixibat

Get in contact with the supplier of your choice:

  1. Syngene International Limited
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.